Guardant Health Inc.

Last updated September 27, 2026

Organization details

Legal name
Guardant Health Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
8071 — Services-Medical Laboratories
Jurisdiction of incorporation
Delaware
Headquarters city
Palo Alto
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
GH
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001576280
EIN
45-4139254

Board of directors

Chief executives

Helmy Eltoukhy · Co-Chief Executive Officer
Dates unknown
AmirAli Talasaz · Co-Chief Executive Officer
Dates unknown

Director election results

Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 15 other boards. 12 are in the same sector.

Network of Guardant Health Inc.'s board connections BioMarin Pharmaceutical Inc. BioMarin Pharmaceutica... Bristol-Myers Squibb Company Bristol-Myers Squibb C... Corvus Pharmaceuticals Inc. Corvus Pharmaceuticals... Denali Therapeutics Inc. Denali Therapeutics In... DexCom Inc. DexCom Inc. Ginkgo Bioworks Holdings Inc. Ginkgo Bioworks Holdin... GoodRx Holdings Inc. GoodRx Holdings Inc. Kyverna Therapeutics Inc. Kyverna Therapeutics I... Olema Pharmaceuticals Inc. Olema Pharmaceuticals... Planet Labs PBC Planet Labs PBC Pliant Therapeutics Inc. Pliant Therapeutics In... Takeda Pharmaceutical Company Limited Takeda Pharmaceutical... Tectonic Therapeutic Inc. Tectonic Therapeutic I... Teva Pharmaceutical Industries Limited Teva Pharmaceutical In... The Boston Beer Company Inc. The Boston Beer Compan... Ian T. Clark Ian T. Clark Kevin R. Sayer Kevin R. Sayer Medina Manuel Hidalgo Medina Manuel Hidalg... Meghan Joyce V Meghan Joyce V Myrtle S. Potter Myrtle S. Potter Roberto Mignone Roberto Mignone Steve E. Krognes Steve E. Krognes Vijaya Gadde Vijaya Gadde Guardant Health Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$78,456
1 purchase by 1 insider
Sold, last 12 months
$172,912,480
140 sales by 15 insiders
Date Insider Transaction Shares Price Value
Nov 12, 2026 Alex M. Azar II Director Option exercise +138 — —
Oct 21, 2026 Roberto Mignone Director Option exercise +264 — —
Oct 17, 2026 Medina Manuel Hidalgo Director Option exercise +232 — —
Oct 16, 2026 Musa Tariq Director Open-market sale −116 $165.88 $19,242
Oct 15, 2026 Musa Tariq Director Option exercise +250 — —
Oct 12, 2026 Alex M. Azar II Director Option exercise +137 — —
Oct 1, 2026 Bell Michael Brian Officer (Chief Financial Officer) Option exercise +2,085 — —
Oct 1, 2026 Chudova Darya Officer (Chief Technology Officer) Option exercise +1,340 — —
Oct 1, 2026 Freeman Chris Officer (Chief Commercial Officer) Option exercise +1,929 — —
Oct 1, 2026 Monroe Terilyn J. Officer (Chief People Officer) Option exercise +2,659 — —
Oct 1, 2026 Saia John G. Officer (Chief Legal Officer) Option exercise +974 — —
Oct 1, 2026 Kalia Kumud Officer (Chief Information Officer) Option exercise +1,607 — —
Oct 1, 2026 Bell Michael Brian Officer (Chief Financial Officer) Option exercise +3,324 — —
Oct 1, 2026 Chudova Darya Officer (Chief Technology Officer) Option exercise +1,668 — —
Oct 1, 2026 Freeman Chris Officer (Chief Commercial Officer) Option exercise +1,668 — —

Organizations in the same sector, closest in location and size first.

Questions about Guardant Health Inc.

Who is the CEO of Guardant Health Inc.?

Helmy Eltoukhy is Guardant Health Inc.'s Co-Chief Executive Officer.

How many directors are on Guardant Health Inc.'s board?

Guardant Health Inc.'s board has 13 directors: Alex M. Azar II, AmirAli Talasaz, Helmy Eltoukhy, Ian T. Clark, Kevin R. Sayer, Medina Manuel Hidalgo, Meghan Joyce V, Musa Tariq, Myrtle S. Potter, Roberto Mignone and 3 others.

Are Guardant Health Inc. insiders buying or selling shares?

Over the last 12 months, Guardant Health Inc. insiders bought $78,456 of shares in 1 purchase and sold $172.9 million of shares in 140 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="guardant-health-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.